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NF-κBFerritin light chain (FTL) reduces the free iron concentration by forming ferritin complexes with ferritin
heavy chain (FTH). Thus, FTL competes with the Fenton reaction by acting as an antioxidant. In the present
study, we determined that FTL inﬂuences the lipopolysaccharide (LPS)-induced inﬂammatory response. FTL
protein expression was regulated by LPS stimulation in RAW264.7 cells. To investigate the role of FTL in LPS-
activated murine macrophages, we established stable FTL-expressing cells and used shRNA to silence FTL
expression in RAW264.7 cells. Overexpression of FTL signiﬁcantly decreased the LPS-induced production
of tumor necrosis factor alpha (TNF-α), interleukin 1β (IL-1β), nitric oxide (NO) and prostaglandin E2
(PGE2). Additionally, overexpression of FTL decreased the LPS-induced increase of the intracellular labile
iron pool (LIP) and reactive oxygen species (ROS). Moreover, FTL overexpression suppressed the LPS-
induced activation of MAPKs and nuclear factor-κB (NF-κB). In contrast, knockdown of FTL by shRNA
showed the reverse effects. Therefore, our results indicate that FTL plays an anti-inﬂammatory role in
response to LPS in murine macrophages and may have therapeutic potential for treating inﬂammatory
diseases.
© 2014 Published by Elsevier B.V.1. Introduction
Ferritin, an iron storage molecule, is mainly localized in the cyto-
plasm, trace amounts are also detected in the serumandother biological
ﬂuids [1]. The cytoplasmic form of mammalian ferritin consists of two
subunits: ferritin heavy chain (FTH) and ferritin light chain (FTL). FTH
has high ferroxidase activity and converts Fe (II) to Fe (III), and FTL
transfers iron from the ferroxidase center to the iron core to improveccharide or endotoxin; TNF-α,
ic oxide; iNOS, inducible nitric
ndin E2; ERK, extracellular-sig-
rrin receptor 1; LIP, labile iron
hlorﬂuorescein-diacetate; SIH,
Laboratory of Molecular Iron
iversity, Shijiazhuang, Hebei
uan0311@163.com (X. Duan).the overall iron sequestering process [2]. High amounts of ferritin
have been observed in inﬂammatory macrophages [3]. Lipopolysaccha-
ride (LPS) addition also induces ferritin expression in the lung [4]. These
data suggest that the increase in intracellular ferritin in macrophages is
related to the secretion of factors by phagocytes. Recently, the functions
of FTH in immunity and the cell apoptosis process have gainedmore at-
tention [5,6]. However, little is known about the functions and mecha-
nism of FTL in the inﬂammatory response, and new functions for the
iron storage protein are yet to be discovered.
LPS, the major outer membrane component in Gram-negative
bacteria, can activate monocytes/macrophages and induce a variety
of immune responses to severe infections, such as septic shock and
systemic inﬂammatory response syndrome (SIRS) [7,8]. The devel-
opment of the inﬂammatory process involves the production of
pro-inﬂammatory cytokines and inﬂammatory mediators, such as
tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), nitric
oxide (NO) and prostaglandin E2 (PGE2), which are the main factors
that mediate the LPS-induced toxic effects [9–11]. The inhibition of
the excess production of pro-inﬂammatory factors is required for
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inﬂammatory diseases. Previous reports showed that MAPKs and
NF-κB signaling pathways are closely related to the LPS-induced
synthesis of TNF-α and IL-1β in macrophages. These signaling path-
ways are also involved in inducible nitric oxide synthase (iNOS) and
cyclooxygenase-2 (COX-2) expression in macrophages, which cata-
lyze the production of NO and PGE2, respectively [12–15]. LPS-
induced reactive oxygen species (ROS) upregulation is a potent
inducer of MAPKs and NF-κB signaling pathways [16]. Free iron,
which is found in the cellular labile iron pool (LIP), acts as a catalytic
agent for Fenton reactions and participates in the generation of free
radicals that possess unpaired electrons such as HO˙. Free radicals
are generally known as ROS and result in oxidative damage [17].
We hypothesized that FTL may exert an anti-inﬂammatory role in
the LPS-induced inﬂammatory response that involves inhibiting LIP
upregulation and ROS production. In the current study, we developed
a RAW264.7 murine macrophage-based cell line that either stably
overexpressed the FTL protein or was depleted of FTL through shRNA
technology. These cells were used to clarify the role of FTL in the LPS-
induced inﬂammatory response in activated macrophages. Our results
demonstrated the role for FTL in LPS-induced activation of signaling
pathways and the development of the inﬂammatory process. Our ﬁnd-
ings suggest that FTL exerts an anti-inﬂammatory role in LPS-induced
inﬂammatory response, and modulation of FTL may be a potential ap-
proach for anti-inﬂammatory therapy.
2. Materials and methods
2.1. DNA constructs
The pcDNA3-Flag-FTL (pFTL) construct was generated by inserting
the mouse Ftl cDNA (NCBI accession number: NM_010240) into
pcDNA3 (Invitrogen, Carlsbad, CA, USA). The Flag epitope tag was intro-
duced at the 3′ end of the coding sequence of the gene. The FTL shRNA
expression vector, pRNA-U6.1/neo-shFTL (shFTL), was constructed
using pRNA-U6.1/neo (GenScript, Piscataway, NJ, USA). To generate an
intermediate plasmid for cloning shRNA targeted to mouse FTL, oligo-
nucleotides sense: 5′-gatccgaacctgaatcaggccctcttcaagagagagggcctga
ttcaggttcttttttggaaa-3′ and antisense: 5′-agcttttccaaaaaagaacctgaatc
aggccctctctcttgaagagggcctgattcaggttcg-3′ were annealed in vitro, and
the resultant double-stranded DNA fragments were subcloned into the
BamHI-HindIII sites of pRNA-U6.1/neo. All of the constructs were
conﬁrmed by DNA sequencing.
2.2. Cell culture and stable transfection
RAW264.7 cells were obtained from the Cell Bank of the Chinese
Academy of Sciences (Shanghai, People’s Republic of China).
RAW264.7 cell clones stably expressing pFTL or shFTLwere constructed
by transfecting the cells with pFTL or shFTL using lipofectamineTM 2000.
Cellswere grown inDulbecco'smodiﬁed Eagle'smedium (GIBCO, Grand
Island, NY) with 10% fetal bovine serum, G418 (600 μg/ml), 100 U/ml
penicillin and 100 μg/ml streptomycin at 37 °C and 5% CO2. The
transfected cells were cultured in the presence of G418, which was
gradually increased to 800 μg/ml. After a period of 4–5 weeks, the
G418-resistant colonies were picked. Corresponding empty vector
clones were used as controls. These clones were then expanded and
screened for the following experiments.
2.3. Antibodies and reagents
Antibodies for FTL, ferritin, TfR1 and NF-κB (p65 subunit) were pur-
chased from Abcam (Hong Kong, China). Antibodies for p38, p44/42
(ERK1/2), IκBα, p-p44/42 (p-ERK1/2) (Thr202/Tyr204), p-p38
(Thr180/Tyr 182) and p-IκBα (Ser32/36) were obtained from Cell Sig-
naling Technology (Danvers, MA, USA). The polyclonal antibody foriNOS was obtained from Cayman (Ann Arbor, MI, USA). The polyclonal
antibody for COX-2 was obtained from Abcam (Burlingame, CA, USA).
All secondary antibodies used for western blotting were purchased
from Cell Signaling Technology. The Flag-tag antibody, LPS, calcein-AM
and DCFH-DA were purchased from Sigma. G418 was from Amresco.
2.4. Reverse transcription-PCR analysis
Total RNAwas extractedwith TRIZOL reagent (Invitrogen) according
to the manufacturer's instructions. A reverse transcription reaction of
2 μg of each total RNA was performed at 42 °C for 1 h. PCR was per-
formed using the Mastercycler Gradient RT-PCR System (Eppendorf)
with the following primers: TNF-α: sense 5′-agcacagaaagcatga-3′, anti-
sense 5′-cagagcaatgactcca-3′; IL-1β: sense 5′-aagctctccacctc-3′, anti-
sense 5′-ctgatgtaccagttg-3′; iNOS: sense 5′-cccttccgaagtttctggcagc-3′,
antisense 5′-ggctgtcagagcctcgtggctt-3′; COX-2: sense 5′-tctccaacctc
tcctatcac-3′, antisense 5′-gcacgtagtcttcgatcact-3′; β-actin: sense 5′-
agccatgtacgtagccatcc-3′, antisense 5′-tttgatgtcacgcacgattt-3′. PCR prod-
ucts were resolved on 1.2% agarose gels and stained with ethidium
bromide. β-actin was used as a loading control where indicated.
2.5. Western blot
Cells were rinsed twice with ice-cold PBS and solubilized in lysis
buffer containing 20 mM Tris (pH 7.5), 135 mM NaCl, 2 mM EDTA,
2 mM DTT, 25 mM b-glycerophosphate, 2 mM sodium pyrophos-
phate, 10% glycerol, 1% Triton X-100, 1 mM sodium orthovanadate,
10 mM NaF, 10 μg/ml aprotinin, 10 μg/ml leupeptin and 1 mM
phenylmethylsulfonyl ﬂuoride (PMSF) for 30 min. Cell lysates were
centrifuged at 15,000 ×g at 4 °C for 15 min [9]. The supernatant
was collected, and the protein concentration was measured with a
Pierce BCA protein assay kit (Thermo Scientiﬁc, Rockford, IL, USA).
Aliquots of the extract containing 50 μg of protein were denatured
in SDS and subjected to SDS–PAGE followed by transfer onto
polyvinylidene diﬂuoride (PVDF) membranes for 90 min at RT. The
membranes were blocked with blocking buffer containing 5% non-
fat milk for 1.5 h at room temperature and then incubated with pri-
mary antibody overnight at 4 °C. The antibody–antigen complexes
were visualized using Super Signal West Pico (Pierce). The total den-
sity of the protein bands was detected with the LAS4000 System
(FujiFilm).
2.6. ELISA assay
RAW264.7 cells were seeded in 24-well plates at 2.5 × 105 cells/well
24 h before the experiments. After LPS treatment, media were collected
and centrifuged at 10,000 rpm for 5 min. The contents of TNF-α, IL-1β
and PGE2 were determined by a quantitative sandwich enzyme-
linked immunosorbent assay (ELISA) using the mouse ELISA kits
(Roche) for TNF-α and IL-1β and PGE2 (Cayman) according to theman-
ufacturers' instructions.
2.7. Nitrite analysis
RAW264.7 cells were seeded in 24-well plates at 2.5 × 105 cells/well
24 h before the experiment. Cells were treatedwith LPS (100 ng/ml) for
12 h. NO synthesis was then determined by assaying the culture super-
natants for nitrite using the Griess reagent (1% sulfanilic acid, 0.1% N-1-
naphthyl-ethylenediamine dihydrochloride, and 5% phosphoric acid) as
described in [9]. Absorbance was measured at 550 nm.
2.8. Immunoﬂuorescence assay
For the detection of the intracellular localization of the NF-κB p65
subunit, cells were grown on glass coverslips at a seeding density of
2 × 104 cells/ml. After LPS (100 ng/ml) treatment for 30 min, the
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then the membrane was permeabilized in 0.2% Triton X-100 in
cold PBS for 30 min. Non-speciﬁc binding sites were blocked with
5% bovine serum albumin (BSA) in PBST (0.2% Tween-20 in PBS) at
room temperature for 30 min. The rabbit anti-NF-κB p65 subunit
(1:300) primary antibody was then incubated with the cells for 1 h
at room temperature. After sufﬁcient washes with PBST, cells were
incubated with FITC-labeled goat anti-rabbit IgG antibody (1:500)
for 1 h at room temperature in the dark and then washed with
PBST for 10 min. Cells were stained with DAPI (1 μg/ml) for 10 min
at 37 °C in the dark followed by sufﬁcient washes with PBS. Stained
cells were analyzed on the Axio Imager A2 microscope (Carl Zeiss)
using an excitation wavelength of 490 nm and an emission wave-
length of 540 nm for FITC and an excitation wavelength of 360 nm
and an emission wavelength of 450 nm for DAPI.
2.9. Labile iron pool measurements
The LIP of the cells was assessed by the calcein-based method.
Brieﬂy, cells were loaded with 100 nM calcein-AM for 30 min at
37 °C after LPS (100 ng/ml) treatment for 30 min and then washed
with PBS three times to remove free dye. Baseline calcein ﬂuores-
cence was measured on a ﬂuorescence plate reader (excitation
488 nm, emission 517 nm). The amount of intracellular iron
bound to calcein was assessed by addition of 100 μM of the speciﬁc
iron chelator SIH (salicylaldehyde isonicotinoyl hydrazone; a gift
from Prof. P. Ponka, Lady Davis Institute for Medical Research, Mon-
treal, Canada) for 30 min followed by measurement of the ﬂuores-
cence signal. Triplicate wells were used for each condition. Cell
viability (assayed by Trypan Blue dye exclusion) was N95% and un-
changed during the assay.
2.10. Measurement of intracellular ROS levels
2′,7′-Dichloroﬂuorescein-diacetate (DCFH-DA) is a well-established
compound for detecting and quantifying intracellular ROS [18]. Intracel-
lular ROS was measured by detecting the ﬂuorescence intensity of DCF
through the DCFH-DA–DCFH-DCF conversion as previously described
[19]. Brieﬂy, after washing with PBS three times, cells were incubated
with DCFH-DA (1 μM) at 37 °C for 30 min in the dark and then treatedFig. 1. LPS induces FTL expression in RAW264.7 cells. (A) RAW264.7 cells were treated with 10
using an anti-FTL antibody. β-actin was used to verify equal loading in each lane. ***, p b 0.00
(5 μg) and empty vector pcDNA3 (5 μg) was used as a control. Cell lysates were subjected to
equal loading in each lane. (C) RAW264.7 cells were stably transfected with shFTL (5 μg) and
western blot analysis with anti-ferritin antibody. β-actin was used to verify equal loading in e
The ﬁgure shows a representative result.with PBS containing 100 ng/ml LPS for 30min. The ﬂuorescencewas de-
tected immediately by ﬂow cytometry at wavelengths of 488 nm for
excitation and 517 nm for emission (FACSCalibur, BD Biosciences).
DCF ﬂuorescence images and cell morphology images were examined
using an Olympus ﬂuorescence microscope (Tokyo, Japan). An in-
creased value compared to control was viewed as the increase of intra-
cellular ROS.
2.11. Measurement of exogenous Flag-FTL iron content
Exogenous Flag-FTL iron content was measured according to the
literature [20]. For the present study, lysates from pcDNA3 stable ex-
pression cells and pFTL stable expression cells were used for immuno-
precipitation (IP) experiments with a Flag antibody.
2.12. Statistical analysis
Statistical analysis used the program SPSS 12.0 (SPSS, Chicago, IL,
USA). Results are expressed as means ± SEM. Differences between
means are determined by one-way ANOVA followed by Student–
Newman–Keuls tests for multiple comparisons and Student's t test for
other data. A value of p b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. LPS induces FTL expression in RAW264.7 cells
An earlier report showed that the lung ferritin content increased sig-
niﬁcantly after the introduction of LPS into the lungs of rats [21]. How-
ever, studies of FTL upregulation in LPS-stimulated macrophages have
not been reported. In the present study, FTL expression in LPS-
stimulated RAW264.7macrophage-like cells was ﬁrst assessed bywest-
ern blot analysis. The RAW264.7 cells were treated with LPS
(100 ng/ml) for 0–24 h. As shown in Fig. 1A, FTL protein expression
was downregulated within the ﬁrst 4 h and upregulated after 6 h of
LPS treatment. These results suggest that FTL may play a regulatory
role in inﬂammatory response to LPS.
To investigate the physiological role of FTL during the LPS-induced
inﬂammatory response, we constructed a FTL shRNA (shFTL) construct
and a Flag-tagged expression plasmid (pFTL).We also established stable0 ng/ml LPS for 0–24 h. FTL protein expression was determined by western blot analysis
1, compared with untreated cells. (B) RAW264.7 cells were stably transfected with pFTL
western blot analysis with anti-Flag and anti-FTL antibodies. β-actin was used to verify
empty vector pRNA-U6.1/neo (5 μg) was used as a control. Cell lysates were subjected to
ach lane. The experiments were repeated three times and similar results were obtained.
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transfecting pFTL and shFTL into RAW264.7 cells, and subsequently
selecting with G418 (Fig. 1B, C).
3.2. FTL inhibits LPS-induced production of TNF-α and IL-1β in RAW264.7
cells
TNF-α and IL-1β, the most important inﬂammatory products, are
primarily involved in promoting the LPS-induced inﬂammatory
response. To evaluate the effect of FTL expression on the production of
pro-inﬂammatory cytokines, pFTL and shFTL RAW264.7 clones were
treated with LPS (100 ng/ml) for 12 h, and the mRNA levels of TNF-α
and IL-1β were determined by RT-PCR. We found that the LPS-
induced increase in TNF-α and IL-1βmRNAwas inhibited in pFTL clones
(Fig. 2A). Further ELISA experiments showed that LPS-induced secretion
of TNF-α and IL-1β increasedmore than 20-fold after 12 h incubation in
the pFTL clones compared with the untreated control cells. In contrast,
there were less TNF-α (Fig. 2B) and IL-1β (Fig. 2C) released from pFTL
cells. Knockdown of FTL by shFTL enhanced the LPS-induced TNF-αFig. 2. FTL inhibits LPS-inducedproduction of TNF-α and IL-1β. (A-C) The stablepFTL andpcDNA
IL-1βmRNA levelsweremeasured by RT-PCR (A). β-actinwas used as a control. The cultureme
**, p b 0.01, compared with untreated pcDNA3 cells; $$$, p b 0.001, $$, p b 0.01, compared with
treated with or without LPS (100 ng/ml) for 12 h. The levels of TNF-α and IL-1βmRNAwere te
ELISA experiments of TNF-α (E) and IL-1β (F) release. ***, p b 0.001, **, p b 0.01, comparedwith
treated shFTL cells. The experiments were repeated three times and similar results were obtainand IL-1βmRNA expression and secretion (Fig. 2D–F). These data dem-
onstrate that FTL plays an anti-inﬂammatory role during the LPS-
induced inﬂammatory response.
3.3. FTL inhibits LPS-induced production of NO and PGE2
NO and PGE2 are critical inﬂammatory mediators that are continu-
ously produced by iNOS and COX-2 in macrophages in the presence of
LPS [22]. To conﬁrm the anti-inﬂammatory function of FTL, we tested
the effect of FTL on mRNA and protein expression of iNOS and COX-2.
As shown in Fig. 3, upon exposure to LPS (100 ng/ml) for 12 h, iNOS
mRNA and protein expression increased more than 2.5-fold and COX-
2 expression increased 7-fold compared with untreated cells. Overex-
pression of FTL in pFTL clones signiﬁcantly inhibited the LPS-induced
mRNA (Fig. 3A) and protein expression (Fig. 3B) of iNOS and COX-2.
To conﬁrm these effects, we measured the secretion of NO and PGE2
in RAW264.7 cells. As shown in Fig. 3C and D, the LPS-induced secretion
of NO and PGE2 increased dramatically after 12 h incubation compared
with untreated control cells. Additionally, there were less NO and PGE23RAW264.7 cloneswere treatedwith orwithout LPS (100 ng/ml) for 12h. Both TNF-α and
diawere collected for ELISA experiments of TNF-α (B) and IL-1β (C) release. ***, p b 0.001,
LPS-treated pFTL cells. (D–F) The stable shFTL and pRNA-U6.1/neo RAW264.7 clones were
sted using RT-PCR (D). β-actin was used as a control. The culture media were collected for
untreated pRNA-U6.1/neo cells; $$$, p b 0.001, $$, p b 0.01, $, p b 0.01, comparedwith LPS-
ed. The ﬁgure shows a representative result.
Fig. 3. FTL inhibits LPS-inducedproduction ofNO and PGE2. (A–D)The pFTL andpcDNA3RAW264.7 cloneswere treatedwith orwithout LPS (100ng/ml) for 12h. ThemRNA levels of iNOS
and COX-2 were measured by RT-PCR (A). β-actin was used as a control. The protein levels of iNOS and COX-2 were determined by western blot analysis (B). β-actin was used to verify
equal loading in each lane. The culturemediawere collected for NO (C) and PGE2 (D) assays as described in theMaterials andmethods. ***,p b 0.001, **, p b 0.01, comparedwith untreated
pcDNA3 cells; $$$, p b 0.001, $$, p b 0.01, compared with LPS-treated pFTL cells. (E–H) The shFTL and pRNA-U6.1/neo RAW264.7 clones were treated with or without LPS (100 ng/ml) for
12 h. The mRNA levels of iNOS and COX-2 were measured by RT-PCR (E). Both iNOS and COX-2 protein expression was determined by western blot analysis (F). The culture media were
collected for NO (G) and PGE2 (H) assay. ***, p b 0.001, **, p b 0.01, comparedwith untreated pRNA-U6.1/neo cells; $$$, p b 0.001, $$, p b 0.01, $, p b 0.05, comparedwith LPS-treated shFTL
cells. The experiments were repeated three times and similar results were obtained. The ﬁgure shows a representative result.
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Fig. 4. FTL suppresses the LPS-induced increase of intracellular LIP andROS. (A)Mean calceinﬂuorescence intensitywasdetected by aﬂuorescence plate reader at an excitationwavelength
of 488 nm and emission of 517 nm in RAW264.7 cells after treatment with LPS (100 ng/ml) for 30 min. The amount of intracellular iron bound to calcein was assessed by addition of the
cell-permeable iron chelator, SIH. Data are mean± SEM (n=5). **, p b 0.01, compared with PBS-treated cells. (B) The exogenous Flag-FTL bound iron wasmeasured by immunoprecip-
itationwith anti-Flag antibody and inductively coupled plasmamass spectroscopy (ICP-MS, Thermo Fisher, X Series, FL, USA). ***, p b 0.001, comparedwith pcDNA3 cells. (C) TfR1 expres-
sion in shFTL cells was determined by western blot analysis. β-actin was used to verify equal loading in each lane. (D) The pcDNA3 or pFTL-transfected RAW264.7 cells were treatedwith
PBS (control) or 100 ng/ml LPS (30 min), and the mean DCF ﬂuorescence intensity was detected by ﬂow cytometry at an excitation wavelength of 488 nm. **, p b 0.01, compared with
untreated pcDNA3-transfected cells; $$, p b 0.01, compared with LPS-treated pcDNA3-transfected cells. The experiments were repeated three times and similar results were obtained.
The ﬁgure shows a representative result.
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enhanced the LPS-induced mRNA and protein expression of iNOS
(Fig. 3E) and COX-2 (Fig. 3F) by at least 1.5-fold compared with LPS-
treated control cells. The mRNA and protein basal level of iNOS and
COX-2 was also signiﬁcantly increased by shFTL in untreated cells.
Moreover, the release of NO (Fig. 3G) and PGE2 (Fig. 3H)was enhanced
in shFTL cells after LPS treatment. Taken together, the effect of FTL on
the production of NO and PGE2 conﬁrmed the anti-inﬂammatory role
of FTL.
3.4. FTL suppresses the LPS-induced increase of intracellular LIP and ROS in
RAW264.7 cells
ROS contributes to the LPS-induced activation of MAPKs, as well as
NF-κB, and induces the pathogenesis of diverse inﬂammatory diseases.
Free iron, known as LIP, acts as a catalytic agent for Fenton reactions
and participates in the generation of ROS [23,24]. To investigate wheth-
er LIP is involved in the LPS-induced activation of MAPKs andNF-κB, we
measured LIP levels using calcein ﬂuorescence as described in theMate-
rials and methods. We treated cells directly with LPS (100 ng/ml) for
30 min and determined the intracellular LIP level. Notably, intracellular
LIP was increased 2.5-fold compared with untreated cells. The LPS-
induced LIP increase was inhibited in pFTL transfected cells (Fig. 4A).
In contrast, the LIP level was higher in shFTL transfected cells than in
LPS-treated control cells (Fig. 4A). These results indicate that FTL plays
an important role in the LPS-induced LIP upregulation and may have a
role in LPS-induced ROS accumulation. Furthermore, we examined the
effect of overexpression of exogenous FTL on ROS production. The re-
sults showed that LPS-induced intracellular ROS production was
inhibited in FTL-overexpressing cells (Fig. 4B). This result is in accor-
dance with a previous report [25].
3.5. FTL suppresses LPS-induced activation of MAPKs and NF-κB
Both MAPKs and NF-κB activation are essential for the expression of
various pro-inﬂammatory genes [26–28]. To investigate whether FTLinhibits the LPS-induced inﬂammatory response by suppressing the
activation of MAPKs and NF-κB, western blot analysis was performed
on LPS-stimulated RAW264.7 murine macrophages. Fig. 5 shows that
incubation of cells with LPS (100 ng/ml) for 30 min led to a 9-fold
increase in p-p44/42 (p-ERK1/2) and a 6.5-fold in p38 phosphorylation.
However, LPS-induced phosphorylation of p44/42 and p38was dramat-
ically inhibited in pFTL cells (Fig. 5A) and increased in shFTL cells
(Fig. 5B). The phosphorylation level of IκBα (p-IκBα) signiﬁcantly in-
creased after LPS (100 ng/ml) stimulation for 30 min. Overexpression
of FTL (pFTL) reduced the p-IκBα level. IκBαwas dramatically degraded
after LPS treatment for 30 min, which was partially recovered in pFTL
cells (Fig. 5C). In contrast, knockdown of FTL by shFTL promoted LPS-
induced IκBα phosphorylation and degradation (Fig. 5D). Additionally,
the intracellular localization of the NF-κB p65 subunit was detected
using an immunoﬂuorescence assay. Overexpression of FTL could inhib-
it the nuclear translocation of NF-κB p65 in LPS-treated RAW264.7 cells
(Fig. 5E).
4. Discussion
As a potent activator of the immune system, LPS induces a variety of
immune responses. Particularly important is the massive activation of
the cytokine cascades in macrophages, which results in severe infection
response such as septic shock and SIRS that have high mortality. Here,
we analyzed the role of FTL in the regulation of themediators of inﬂam-
mation.We used RAW264.7 cells and not macrophage primary cultures
because RAW264.7 cells have a transfection efﬁciency that is 1000-fold
better than macrophage primary cultures.
TNF-α and IL-1β are two pro-inﬂammatory cytokines that play a
pivotal role in the host immune response [29]. TNF-α is themost impor-
tant initiator of the cytokine cascades. When cytokine production
increases to such an extent that it moves outside of the local infection,
sepsis or SIRS ensues. IL-1 is a potent inﬂammatory cytokine with vari-
ous biological activities involved in regulating host defense and the im-
mune response [30]. NO and PGE2, which play central roles in the
pathogenesis of diverse inﬂammatory and infectious disorders [31,32],
Fig. 5. FTL suppresses LPS-induced activation of MAPKs and NF-κB. (A) The pFTL and pcDNA3 RAW264.7 clones were treated with or without LPS (100 ng/ml) for 30 min. The protein levels of p-p44/42, p44/42, p-p38 and p38 were determined by
western blot analysis. ***, p b 0.001, comparedwith untreated pcDNA3 cells; $$$, p b 0.001, $$, p b 0.01, comparedwith LPS-treated pFTL cells. β-actinwas used to verify equal loading in each lane. (B) The shFTL and pRNA-U6.1/neo (control) clones of
RAW264.7 cells were treated with or without LPS (100 ng/ml) for 30 min. The p-p44/42, p44/42, p-p38 and p38 protein levels were tested using western blot analysis. ***, p b 0.001, compared with untreated pRNA-U6.1/neo cells; $$$, p b 0.001,
compared with LPS-treated shFTL cells. β-actin was used to verify equal loading in each lane. (C) The pFTL and pcDNA3 RAW264.7 clones were treated with or without LPS (100 ng/ml) for 30 min. Both p-IκBα and IκBα protein expression was
determined by western blot analysis. ***, p b 0.001, **, p b 0.01, compared with untreated pcDNA3 cells; $$$, p b 0.001, $$, p b 0.01, compared with LPS-treated pFTL cells. β-actin was used to verify equal loading in each lane. (D) The shFTL and
pRNA-U6.1/neo clones of RAW264.7 cells were treated with or without LPS (100 ng/ml) for 30 min. The protein levels of p-IκBα and IκBαwere tested by western blotting. **, p b 0.01, *, p b 0.05, compared with untreated pRNA-U6.1/neo cells;
$$, p b 0.01, compared with LPS-treated shFTL cells. β-actin was used to verify equal loading in each lane. (E) Localization of NF-κB was analyzed by double immunoﬂuorescence staining of NF-κB p65 subunit (green) and nucleus (blue). Immuno-
ﬂuorescence images were acquired by using an Axio Imager A2 microscope. All magniﬁcations are 200×. The experiments were repeated three times and similar results were obtained. The ﬁgure shows a representative result.
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LPS-induced inﬂammation and damage in addition to TNF-α and IL-
1β. NO, which is synthesized from arginine by iNOS, is over-produced
by activatedmacrophages and is important in the pathogenesis of septic
shock and inﬂammatory tissue injury. PGE2 is a primary product of
arachidonic metabolism, and over-production has been shown to play
a crucial role in initiating systemic inﬂammatory response during sepsis
[33]. PGE2 is synthesized via COX-2 [15]. Productionof NO and PGE2 can
cause pain, fever, swelling, and tenderness [34]. Thus, for treatment of
severe infection, it is important to inhibit the LPS-induced production
of TNF-α, IL-1β, NO and PGE2 to block the early cytokine cascades.
In the present study, the FTL protein level was upregulated in
RAW264.7 cells, a murine macrophage-like cell line, after 6 h stimula-
tion with LPS. This result suggests that FTL may speciﬁcally mediate
LPS-triggered inﬂammatory signaling in RAW264.7 cells. We ﬁrst
showed that overexpression of FTL inhibits LPS-induced transcription
of TNF-α and IL-1β as well as expression of iNOS and COX-2. Further-
more, FTL inhibited the release of TNF-α, IL-1β, NO and PGE2 from
RAW264.7 cells. All these data were conﬁrmed by FTL RNA interfering
experiments. These data suggest that FTL acts as an anti-inﬂammatory
factor in the LPS-induced inﬂammatory response.
Proper cellular iron handling and storage are the roles of ferritin,
and any malfunction may cause iron mishandling that can lead to
pathological consequences. Mutations in the FTL gene make the mol-
ecule susceptible to oxidation and cause hereditary ferritinopathy
and neurodegeneration [35–37]. Free iron acts as a catalytic agent
for ROS and results in inﬂammation [23,34]. Although LPS-induced
oxidative stress is well-documented, the source and the mechanism
of ROS formation remain elusive. Based on our ﬁndings, the mecha-
nism that likely accounts for the anti-inﬂammatory action of FTL in-
volves the inhibition of LPS-induced intracellular LIP upregulation, as
well as ROS production, through iron sequestration. In the present
study, overexpression of FTL reduced the free iron concentration
and subsequent ROS production. Thus, FTL competed with the
Fenton reactions and acted as an antioxidant because of the iron se-
questration ability of exogenous FTL (Fig. 4B). Transient transfection
of FTL shRNA resulted in a decreased expression of transferrin recep-
tor protein 1 (TfR1) (Fig. 4C), which is a molecule essential for iron
uptake. These data suggest that knockdown of FTL reduces ferritin
complex and the free iron concentration is upregulated. The increase
of intracellular free iron inhibited TfR1 expression.
Our data also showed the downregulation of FTL within the ﬁrst 4 h
of LPS stimulation. LPS stimulation directly increases NADPHoxidase ac-
tivity, which is associated with an increased intracellular ROS level [38].
Interestingly, FTL seems to be more sensitive to oxidation [39]. The FTL
content is decreased due to the oxidation of intracellular ferritin, and
the consequent proteasomal degradation reduced the ferritin content
[17,39–42]. The experiment with the proteasomal inhibitor MG-132
(presented in supplementary Fig. 1) provided evidence that the protea-
some is instrumental in the turnover of FTL. As a consequence of FTL
degradation, an expansion of the free iron pool is likely to occur [42,
43]. Iron plays a critical role during this process because it catalyzes
the generation of free radicals formed from hydrogen peroxide via the
Fenton reaction. Basal ROS production is boosted by expansive iron re-
leased from ferritin and accelerates ferritin degradation [39,43]. At the
same time, the increased availability of iron induces ferritin gene tran-
scription [42,43]. The speciﬁc iron chelator SIH inhibited LPS-induced
protein expression of FTL (supplementary Fig. 2). Excess iron, caused
by the increase of the ferritin synthetic rate, may allow reconstitution
of ferritin content in an attempt to limit iron bioavailability. The high
level of FTL following recovery might represent an adaptive response
to oxidative stress because ferritin may be a protein with antioxidative
properties [44,25]. It is possible that the synthesis of ferritin may not
only return to normal levels but also increase at later time points. We
hypothesized that the basal ROS production induced by LPS caused
FTL degradation and cooperated to increase intracellular free iron levelswithin the ﬁrst 4 h of LPS stimulation. This expansion of the iron pool in-
duces the accumulation of more ferritin during the recovery period in
RAW264.7 cells in the attempt to limit iron bioavailability.
Many previous reports indicated that ROS production was required
for LPS-induced activation of MAPKs and NF-κB and the subsequent
production of inﬂammatory cytokines [45–52]. Not surprisingly, we fur-
ther found that FTL overexpression suppressed LPS-induced ERK, p38
and NF-κB activation.
In conclusion, our results reveal a novel role for FTL as an anti-
inﬂammatory factor in the cellular response to LPS and provide new in-
sight for understanding the detailed mechanisms of FTL regulation of
the LPS-triggered inﬂammatory response. Thus, FTL may not only be a
major iron storage protein but also an important regulator of the inﬂam-
matory response. Though previous reports showed that the induction of
FTL synthesis was mediated by NO [53,54], TNF-α [55], IL-1β [56] and
oxidative stress [25], the other factors that control the FTL expression
level and inﬂammatory mediator production during activation of
RAW264.7 cells remain to be investigated. Our study indicates a poten-
tial anti-inﬂammatory role for FTL in inﬂammatory diseases.
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